MYLAN 8015 MYLAN 8015 (Lansoprazole delayed release 15 mg)
Pill imprint MYLAN 8015 MYLAN 8015 has been identified as Lansoprazole delayed release 15 mg.
Lansoprazole is used in the treatment of barrett's esophagus; erosive esophagitis; gerd; helicobacter pylori infection; gastritis/duodenitis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 15 mg is not a controlled substance under the Controlled Substance Act (CSA).
- MYLAN 8015 MYLAN 8015
- 15 mg
- Rx and/or OTC
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
low substituted hydroxypropyl cellulose
methacrylic acid - ethyl acrylate copolymer (1:1) type a
FD&C Green No. 3
FD&C Red No. 40
More about lansoprazole
- Lansoprazole delayed-release capsules
- Lansoprazole orally disintegrating tablets
- Lansoprazole powder packet
- Lansoprazole (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.